IB Acquisition (IBACR) Stock: Why It's Down Today
Updated Oct 20, 2026, 4:00 PM ET · closing price
- Closed at $0.11, -4.57% vs the prior close of $0.11.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
IBACR slides 4.6% to $0.11. Closed at $0.11, -4.57% vs the prior close of $0.11. Day range $0.11–$0.11, opened at $0.11.
IBACR daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — IBACR slides 4.6% to $0.11
- Closed at $0.11, -4.57% vs the prior close of $0.11. Day range $0.11–$0.11, opened at $0.11.
- 52-week range $0.11–$0.11; today's close sits at 0% of that range, 4.6% below the 52-week high.
IBACR bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $3.42M.
- Share count down 68.2% in a year (buybacks).
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 4.6% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
IBACR latest news & SEC filings
Every SEC filing by or about IBACR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.08 — Set shareholder nomination dates.
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Sep 23, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 4, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 25, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$567.17K (prior year $818.61K) (loss widened vs Jun 30, 2025)
Things to know before you trade IBACR
- How much it moves: over the last 20 sessions the average daily move was 4.57% (largest 4.6%). That is a volatile stock.
- Liquidity: about 100 shares (≈$11) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.11 vs a range of $0.11–$0.11 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Arbitrage Llc Aqr sold 6,262 shares on Mar 23, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 6, 2026; 8-K Sep 30, 2026.
- Share count: 5.01M shares outstanding (Aug 14, 2026), -68.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
IBACR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.11 | 0.11 | 0.11 | 0.11 | 200 |
| Oct 14, 2026 | 0.00 | 0.11 | 0.11 | 0.11 | 0 |
About IB Acquisition
IB Acquisition (IBACR) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in BOCA RATON, FL. State of incorporation: NV. Fiscal year ends September 30. SEC CIK 1998781.
IBACR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 6,262 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 40,144 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 56,145 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,623 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 25,087 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 138,005 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 29,888 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,059 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 26,410 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 10,377 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 6,262 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 40,144 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 56,145 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 1,623 | $10.80 |
| Mar 23, 2026 | Arbitrage Llc Aqr | Sale | 25,087 | $10.80 |
IBACR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $3.42M | — | $-1.32M |
| Sep 30, 2024 | — | $1.87M | — | $-820.96K |
| Sep 30, 2023 | — | $-6.84K | — | $-207 |
Latest balance sheet: total assets $8.52M, total liabilities $2.45M, cash $30.16K (as of Jun 30, 2026).
IBACR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Medpace (MEDP)Icon (ICLR)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on IBACR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.